BEGIN:VCALENDAR VERSION:2.0 METHOD:PUBLISH PRODID:-//ACC//Meetings//EN BEGIN:VTIMEZONE TZID:Eastern Standard Time BEGIN:STANDARD DTSTART:16011101T020000 RRULE:FREQ=YEARLY;BYDAY=1SU;BYMONTH=11 TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:Eastern Standard Time END:STANDARD BEGIN:DAYLIGHT DTSTART:16010301T020000 RRULE:FREQ=YEARLY;BYDAY=2SU;BYMONTH=3 TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:Eastern Daylight Time END:DAYLIGHT END:VTIMEZONE BEGIN:VEVENT DESCRIPTION:Previously\, treatment for tricuspid valve regurgitation was mo st commonly performed on patients undergoing left sided valve surgery. Rec ently\, there has been an explosion of novel percutaneous treatment modali ties. Join the ACC's CV Imaging Section as we review and discuss the curre nt state of tricuspid valve disease and available treatment options using a case-based approach.\nLearning objectives:\nUnderstand the anatomy of th e tricuspid valve and the prognosis of chronic tricuspid valve regurgitati on\nUnderstand the essentials of multimodality imaging of the tricuspid va lve before\, during and after tricuspid valve intervention\nUnderstand the different treatment options including novel percutaneous devices currentl y under investigation for treatment of chronic\, severe tricuspid regurgit ation.\n\n\n\n\n\n\nACC Members\, discuss this on Member Hub\n\n\n\n .v ideoWrapper {\n position: relative\;\n padding-bottom: 56.25%\; /* 1 6:9 */\n padding-top: 25px\;\n height: 0\;\n }\n .videoWrapper iframe {\n position: absolute\;\n top: 0\;\n left: 0\;\n widt h: 100%\;\n height: 100%\;\n }\n DTEND;TZID=Eastern Standard Time:20220210T191500 DTSTAMP:20260526T105708Z DTSTART;TZID=Eastern Standard Time:20220210T190000 LOCATION:Online - Eastern Time (ET) SEQUENCE:0 SUMMARY:New Innovations in Management of Tricuspid Valve Regurgitation UID:f85ae220-10ea-4545-ab4e-909dde9dfb51@acc.org X-ALT-DESC;FMTTYPE=text/html:

Previously\, treatment fo r tricuspid valve regurgitation was most commonly performed on patients un dergoing left sided valve surgery. Recently\, there has been an explosion of novel percutaneous treatment modalities. Join the ACC's CV Imaging Sect ion as we review and discuss the current state of tricuspid valve disease and available treatment options using a case-based approach.

\n

Learn ing objectives:

    \n
  1. Understand the anatomy of the tricuspid valve and the prognosis of chronic tricuspid valve regurgitation
    2. \n
  2. Understa nd the essentials of multimodality imaging of the tricuspid valve before\, during and after tricuspid valve intervention
    3. \n
  3. Understand the di fferent treatment options including novel percutaneous devices currently u nder investigation for treatment of chronic\, severe tricuspid regurgitati on.

\n\n
\n\n


\n\n
\nACC Members\, discuss this on Member Hub\n
\ n\n